Description

Argipressin, Beta Mercapto-Beta,β-Cyclopentamethylenepropionic Acid(1)-o-Methyl-Tyr(2)-Tyrnh2(9)- is a synthetic, nonapeptide analog of vasopressin, engineered with specific structural modifications to enhance its stability and receptor-binding profile. This compound is critical for advanced pharmaceutical research and development, particularly in the study of vasopressin receptor-mediated pathways. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of novel therapeutics for conditions related to fluid balance, cardiovascular function, and central nervous system disorders.

Application

• Pharmaceutical Reference Standard: Serves as a high-purity analytical standard for quality control and method validation in drug development and manufacturing.
• Biochemical Research: Used in vitro and in vivo studies to investigate the physiological roles and signaling mechanisms of vasopressin V1a and V2 receptors.
• Drug Discovery: A key intermediate or active pharmacophore in the design and synthesis of new peptide-based therapeutics targeting hypertension, diabetes insipidus, or bleeding disorders.
• Clinical Research: Potential application in preclinical and clinical trials for evaluating the efficacy and safety of novel vasopressin analogs.
• Diagnostic Development: May be employed in the development of diagnostic assays or kits for hormonal disorders.

Basic Information

Product Name	Argipressin, Beta Mercapto-Beta,β-Cyclopentamethylenepropionic Acid(1)-o-Methyl-Tyr(2)-Tyrnh2(9)-
CAS No.	114872-15-0
Molecular Formula	C46H65N13O12S2
Molecular Weight	1040.2 g/mol
Synonyms	[1-(β-Mercapto-β,β-cyclopentamethylenepropionic acid), 2-(O-methyl-L-tyrosine), 9-(L-tyrosinamide)]-vasopressin; [Mpa1, Tyr(Me)2, Tyr-NH29]-AVP; Desmopressin analog; Vasopressin V2 receptor agonist analog; (1-β-Mercaptocyclohexanepropionic acid, 2-O-methyltyrosine, 9-tyrosinamide)-vasopressin; Argipressin, [1-(3-mercapto-3,3-cyclopentamethylenepropanoic acid), 2-O-methyltyrosine, 9-tyrosinamide]-; AVP analog 114872-15-0
EINECS	Contact for details

Quality Control

Our Argipressin analog is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and mass spectrometry for identity confirmation, to ensure it meets exacting standards for research use. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment. We support compliance with relevant guidelines for active pharmaceutical ingredients (APIs).

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label. This product is hygroscopic (moisture-sensitive) and should be kept in a dry environment. For long-term storage, consider desiccated conditions at -20°C.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Retention time corresponds to reference standard
Identification (MS)	Mass spectrum conforms to theoretical values
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Water Content (KF)	≤ 5.0%
Peptide Content	≥ 80.0% (on anhydrous basis)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.